Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators

Figure 3

IL-17 expression. (a) IL-17 concentrations in pg/mL in the serum of control subjects and NASH patients. IL-17 was measured by ELISA as described in Section 2. Data represent mean ± SEM in triplicate (ELISA) from 39 different donors/sera of NASH patients. The levels of IL-17 were significantly increased in NASH patients and NASH patients with fibrosis compared with control subjects, with and , respectively. (b) On the mRNA level, IL-17A mRNA is overexpressed in NASH patients with ().

(a)

(b)